Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Angiodynamics Inc
(NQ:
ANGO
)
7.510
+0.110 (+1.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
307,447
Open
7.520
Bid (Size)
7.280 (1)
Ask (Size)
7.900 (2)
Prev. Close
7.400
Today's Range
7.325 - 7.530
52wk Range
5.260 - 8.250
Shares Outstanding
38,444,076
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes
September 19, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024
September 19, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Performance
YTD
-6.48%
-6.48%
1 Month
+1.21%
+1.21%
3 Month
+26.64%
+26.64%
6 Month
+27.94%
+27.94%
1 Year
+3.73%
+3.73%
More News
Read More
AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
September 03, 2024
From
AngioDynamics, Inc.
Via
Business Wire
PDD Holdings, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
August 26, 2024
Via
Benzinga
AngioDynamics to Participate in Upcoming Investor Conferences
July 29, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Nasdaq Edges Lower; Morgan Stanley Earnings Top Views
July 16, 2024
Via
Benzinga
Medical Devices Maker AngioDynamics Lays Out Growth Plans, Issues Upbeat Annual Guidance
July 16, 2024
Via
Benzinga
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 16, 2024
Via
Benzinga
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
July 16, 2024
Via
Benzinga
Exposures
Fossil Fuels
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
July 16, 2024
Via
Benzinga
ANGO Stock Earnings: AngioDynamics Beats EPS, Beats Revenue for Q4 2024
July 16, 2024
Via
InvestorPlace
AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results
July 16, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024
July 08, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System
May 21, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
May 06, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Insiders Buying Zumiez And 3 Other Stocks
April 09, 2024
Via
Benzinga
Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars
April 04, 2024
Via
Benzinga
Exposures
Product Safety
ANGO Stock Earnings: AngioDynamics Misses EPS, Misses Revenue for Q3 2024
April 04, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 04, 2024
Via
InvestorPlace
AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
April 04, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE
April 04, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Earnings Scheduled For April 4, 2024
April 04, 2024
Via
Benzinga
AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement
April 02, 2024
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
April 01, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
March 19, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.